3rd Annual Artificial Intelligence in Drug Development Congress

25 – 26 September∣London UK

 

Oxford Global are delighted to announce the 3rd Annual Artificial Intelligence in Drug Development Congress, returning to London on 25 – 26 September this year. The revamped agenda for 2019 features 2 interactive streams addressing the key challenges & opportunities in AI in drug discovery, discovery chemistry & machine learning.  

 

Machine learning technologies are predicted to influence the search for new & advanced pharmaceuticals quicker, cheaper & more effectively. These technologies are becoming increasingly important, but challenges remain. Do not miss out on attending this event, to stay at the forefront of AI research!  

 

Speakers Include:  

• Kristen Fortney, Founder & CEO, BioAge Labs 
• Sameen Desai, Director, Celgene 
• Friedrich Rippmann, Director, Merck KGaA 
• Bhushan Bonde, Head, UCB 
• Arndt Schmitz, Senior Technology Expert, Bayer AG 

 

View Agenda: https://bit.ly/2FdlK43

 

Forming part of our PharmaTec Event Series, the congress is co-located with the established 17th Annual Pharmaceutical IT & Data Congress as well as SmartLabs & Laboratory Informatics Congress & Cyber Security & Data Protection in Pharma & Healthcare Congress.  

 

Attracting over 450 delegates across all events within the series, do not miss out on registering now as spaces are filling up fast! For the latest conference updates please contact our marketing team at d.dalby@oxfordglobal.co.uk